Effects of chronic marijuana use on endothelial function

长期吸食大麻对内皮功能的影响

基本信息

项目摘要

PROJECT SUMMARY This is a clinical observational study that will fill an important gap in our understanding of how marijuana use, and secondhand exposure, impact cardiovascular health. A likely consequence of marijuana legalization is that intentional smoking of cannabis, and involuntary secondhand exposure, will greatly increase in coming years. While some retrospective human association studies have failed to find clear-cut associations between marijuana smoking and cardiovascular disease, other studies have indicated that marijuana use increases the risk of subsequent myocardial infarction (MI) and heart failure. It is unclear whether these adverse effects are caused by the cannabinoids or the smoke. Nonetheless, despite public awareness that tobacco smoke is harmful, many people still assume that marijuana smoke is benign. Moreover, cardiovascular effects of secondhand smoke (SHS) exposure have remained relatively unexplored in human studies. There is increasing evidence in rats that both active marijuana smoking and marijuana SHS exposure causes vascular endothelial dysfunction. While the endothelial dysfunction is transient, clinical studies have shown that not only do tobacco smokers have endothelial dysfunction, but repeated exposures to SHS lead to chronic dysfunction as well. Therefore, it is important to determine in humans if chronic active or passive marijuana smoking similarly causes endothelial dysfunction. The overall hypothesis of this proposal is that active use of marijuana, or secondhand exposure, causes adverse cardiovascular consequences in humans. The overarching goal is to test this hypothesis by measur- ing a panel of functional indicators and circulating biomarkers of cardiovascular risk, in otherwise healthy sub- jects who are actively or passively exposed on a regular basis in their daily lives to cannabis (this proposal does not involve exposing humans to cannabis). The impact is that an improved understanding of the adverse cardiovascular effects of intentional or involuntary exposure to cannabis will better inform personal health behavior, advice of physicians to their patients, public health policy decisions, legal doctrines, and potential regulation of the cannabis industry and its products. Aim 1 is to determine if vascular function is impaired by chronic active or passive marijuana smoking in otherwise healthy individuals (age ≤50), relative to tobacco smokers and to people who avoid exposure to tobacco and marijuana. Aim 2 is to determine if these chronic exposure conditions increase biomarkers of cardiovascular risk in the blood. Aim 3 is to determine if cultured endothelial cells incubated in sera from exposed individuals undergo adverse functional changes relative to non-users’ sera, indicating potential mechanisms by which vascular function is being impaired by exposure to these products.
项目总结 这是一项临床观察性研究,将填补我们对大麻如何 使用和二手接触会影响心血管健康。大麻合法化的可能后果 是故意吸食大麻,以及非自愿的二手烟接触,在未来将大大增加 好几年了。虽然一些回溯性的人类关联研究未能找到明确的关联 除了吸食大麻和心血管疾病外,其他研究也表明,吸食大麻会增加 继发心肌梗死(MI)和心力衰竭的风险。目前尚不清楚这些不良影响是否 是由大麻或烟雾引起的。尽管如此,尽管公众意识到烟草烟雾是 尽管有害,但许多人仍然认为大麻烟是无害的。此外,对心血管的影响 在人体研究中,暴露于二手烟(SHS)的研究相对较少。的确有 越来越多的证据表明,主动吸食大麻和暴露于大麻SHS都会导致血管 内皮功能障碍。虽然内皮功能障碍是暂时的,但临床研究表明,不仅 吸烟者是否有内皮功能障碍,但反复暴露于SHS会导致慢性功能障碍 也是。因此,重要的是要确定人类是长期吸食主动大麻还是被动吸食大麻。 同样会导致内皮功能障碍。 这项提议的总体假设是,积极使用大麻或接触二手烟会导致 对人类的心血管不良后果。首要目标是通过测量以下各项来检验这一假设: 在其他健康的亚健康人群中,检测心血管风险的功能指标和循环生物标记物 在日常生活中经常主动或被动接触大麻的对象(此建议 不涉及使人类接触大麻)。其影响是,提高了对不利因素的理解 故意或非自愿接触大麻对心血管的影响将更好地促进个人健康 行为、医生对病人的建议、公共卫生政策决策、法律原则和潜力 大麻产业及其产品的监管。目标1是确定血管功能是否因 与烟草相关的其他健康个体的慢性主动或被动吸食大麻(年龄≤50) 吸烟者和避免接触烟草和大麻的人。目标2是确定这些慢性疾病 暴露条件会增加血液中心血管风险的生物标志物。目标3是确定是否培养了 在暴露个体的血清中培养的内皮细胞经历了与以下方面相关的不利功能变化 非使用者的血清,表明暴露于空气中可能导致血管功能受损 这些产品。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATTHEW Lawrence SPRINGER其他文献

MATTHEW Lawrence SPRINGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATTHEW Lawrence SPRINGER', 18)}}的其他基金

Upregulation of SARS-CoV-2 receptor and activation proteases by marijuana smoke and e-cigarette aerosols
大麻烟雾和电子烟气溶胶上调 SARS-CoV-2 受体和激活蛋白酶
  • 批准号:
    10246725
  • 财政年份:
    2020
  • 资助金额:
    $ 70.1万
  • 项目类别:
Measuring relative cardiovascular health risks of inhaled tobacco products
测量吸入烟草制品的相对心血管健康风险
  • 批准号:
    8852703
  • 财政年份:
    2014
  • 资助金额:
    $ 70.1万
  • 项目类别:
Measuring relative cardiovascular health risks of inhaled tobacco products
测量吸入烟草制品的相对心血管健康风险
  • 批准号:
    9298337
  • 财政年份:
    2014
  • 资助金额:
    $ 70.1万
  • 项目类别:
Measuring relative cardiovascular health risks of inhaled tobacco products
测量吸入烟草制品的相对心血管健康风险
  • 批准号:
    8685741
  • 财政年份:
    2014
  • 资助金额:
    $ 70.1万
  • 项目类别:
PROJECT 3: CARDIOVASCULAR HEALTH EFFECTS OF EMERGING HEAT-NOT-BURN TOBACCO PRODUCTS
项目 3:新兴加热不燃烧烟草产品对心血管健康的影响
  • 批准号:
    10259838
  • 财政年份:
    2013
  • 资助金额:
    $ 70.1万
  • 项目类别:
PROJECT 3: CARDIOVASCULAR HEALTH EFFECTS OF EMERGING HEAT-NOT-BURN TOBACCO PRODUCTS
项目 3:新兴加热不燃烧烟草产品对心血管健康的影响
  • 批准号:
    10468884
  • 财政年份:
    2013
  • 资助金额:
    $ 70.1万
  • 项目类别:
Evaluation of harmful effects of cannabis smoke on vascular endothelial function
大麻烟雾对血管内皮功能有害影响的评价
  • 批准号:
    8330780
  • 财政年份:
    2011
  • 资助金额:
    $ 70.1万
  • 项目类别:
Evaluation of harmful effects of cannabis smoke on vascular endothelial function
大麻烟雾对血管内皮功能有害影响的评价
  • 批准号:
    8174578
  • 财政年份:
    2011
  • 资助金额:
    $ 70.1万
  • 项目类别:
Bone marrow cell therapy for cardiac disease: Impact of donor age and infarction
骨髓细胞治疗心脏病:捐赠者年龄和梗塞的影响
  • 批准号:
    8091451
  • 财政年份:
    2010
  • 资助金额:
    $ 70.1万
  • 项目类别:
Bone marrow cell therapy for cardiac disease: Impact of donor age and infarction
骨髓细胞治疗心脏病:捐赠者年龄和梗塞的影响
  • 批准号:
    7990014
  • 财政年份:
    2010
  • 资助金额:
    $ 70.1万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 70.1万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 70.1万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.1万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了